About
Peter Wolpert is CEO at Industrifonden, which he joined in 2022, and has over 25 years of experience in CEO, founder, board, and advisory roles. He founded and led Moberg Pharma, which was acquired by US private equity firms Roundtable Healthcare Partners and Signet Healthcare Partners, and began his career at Ericsson and McKinsey & Co. He holds an M.Sc. in Engineering Physics from the Royal Institute of Technology and an M.Sc. in Finance and Business Administration from the Stockholm School of Economics.
Contact· self-published, not guessed
Invests in
BiotechDeep Tech
Experience
- Purpose PharmaBoard Membercurrent2023 — presentStockholm, Stockholm County, Sweden
- Swedish Private Equity & Venture Capital AssociationBoard Membercurrent2022 — presentStockholm, Stockholm County, Sweden
- IndustrifondenCEOcurrent2022 — present
- A3P BiomedicalSenior Advisor2020 — 2022
- Moberg Pharma ABChairman & Founder2019 — 2022NJ, USA
- Moberg Pharma ABCEO and Founder2006 — 2019Stockholm, Sweden
- Oncozenge ABChairman of Advisory Board2020 — 2022
- WABSenior Advisor2020 — 2022Stockholm, Stockholm County, Sweden
- MedUniverseBoard Director2016 — 2021
- Wolpert ConsultingOwner2002 — 2006
- Accuro ImmunologyCo-founder, Chairman1999 — 2006
- Athera BiotechnologyCEO2003 — 2006
- McKinseyAssociate1996 — 1999
Skills & more
Strategy45Start-ups39Biotechnology37Lifesciences16Business Development12Biopharmaceuticals12Leadership6Venture Capital10Hardware Diagnostics3Drug Delivery1Entrepreneurship9Business Strategy7
+12 more
Pharmaceutical IndustryMergers & AcquisitionsTechnology TransferCorporate DevelopmentManagement ConsultingBusiness PlanningMarketing StrategyNew Business DevelopmentClinical DevelopmentClinical TrialsCommercializationRFrom Peter's professional profile.
Colleagues at Industrifonden
Andreas Hiller
Investor at Industrifonden
Andreas Söneby
Investor at Industrifonden
Anna Haupt
Investor at Industrifonden
Anna Ljungdahl
Investor at Industrifonden
Åsa Hedin
Investor at Industrifonden
Åsa Sundberg
Investor at Industrifonden
Birgitta Stymne Göransson
Investor at Industrifonden
Caroline Murray
Investor at Industrifonden
Frequently asked questions
- Who is Peter Wolpert?
- Peter Wolpert is CEO at Industrifonden, which he joined in 2022, and has over 25 years of experience in CEO, founder, board, and advisory roles. He founded and led Moberg Pharma, which was acquired by US private equity firms Roundtable Healthcare Partners and Signet Healthcare Partners, and began his career at Ericsson and McKinsey & Co. He holds an M.Sc. in Engineering Physics from the Royal Institute of Technology and an M.Sc. in Finance and Business Administration from the Stockholm School of Economics.
- Where does Peter Wolpert work?
- Peter Wolpert is CEO at Industrifonden.
- What does Peter Wolpert invest in?
- Peter Wolpert invests in Biotech, Deep Tech.
- Where did Peter Wolpert go to school?
- Peter Wolpert studied at Stockholm School of Economics (MSc in BA, Finance); KTH Royal Institute of Technology (MSc in Engineerings Physics, Applied Mathematics).
Same school
Also attended Stockholm School of Economics215
Jeppe RindomCo-founder & CEO of PleoVictor JacobssonCo-founder of Klarna; investorJosefin LandgårdCo-founder & CEO of MANTLE; co-founder of KryMattias LjungmanInvestor at Moonfire VenturesPär-Jörgen PärsonPartner at NorthzoneJessica SchultzPartner at Northzone
+ 209 more
Also attended KTH Royal Institute of Technology135
Ali GhodsiCo-founder & CEO of DatabricksWilliam JilltoftDirector of Strategy and Operations at NorthzoneJohanna OlnénData Analyst at NorthzoneRobin WänlundAssociate at Notion CapitalMagnus BergmanInvestor at Luminar VenturesGiuseppe LacerenzaPartner at Keen Venture Partners
+ 129 more
